Topoisomerase-specific drug sensitivity in relation to cell cycle progression.
about
AMF1 (GPS2) modulates p53 transactivationhMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaksEtoposide induces nuclear re-localisation of AIDModulation of cell cycle by graded expression of MLL-AF4 fusion oncoproteinNuclear expression of dynamin-related protein 1 in lung adenocarcinomas.Early G2/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations.Caspases target only two architectural components within the core structure of the nuclear pore complex.The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabineDNA topoisomerase II sites in the histone H4 gene during the highly synchronous cell cycle of Physarum polycephalumMechanisms of multidrug resistance in cancer treatment.Programmed cell death: concept, mechanism and control.Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: influence of growth kinetics, growth environment and DNA packaging.Drug-induced death of leukaemic cells after G2/M arrest: higher order DNA fragmentation as an indicator of mechanism.Apoptosis. Biochemical events and relevance to cancer chemotherapy.Characterisation of VP-16-induced DNA cleavage in oestrogen-stimulated human breast cancer cells.Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress responseEffect of cycloheximide on development of methotrexate resistance of Chinese hamster ovary cells treated with inhibitors of DNA synthesis.RNAi screening uncovers Dhx9 as a modifier of ABT-737 resistance in an Eμ-myc/Bcl-2 mouse model.Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death.The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene.Hepatocyte growth factor induces hypoxia-related interleukin-8 expression in lung adenocarcinoma cells.Sequence of treatment is important in the modification of camptothecin induced cell killing by hyperthermia.DNA topoisomerase II activity in nonreplicating, transcriptionally inactive, chicken late spermatids.Critical DNA target size model of ionizing radiation-induced mammalian cell death.Untangling the role of DNA topoisomerase II in mitotic chromosome structure and function.Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines.Pre-treatment of a human T-lymphoblastoid cell line with L-asparaginase reduces etoposide-induced DNA strand breakage and cytotoxicity.Competence growth factors can cause modification in higher-order chromatin structure in mouse embryo 3T3 fibroblasts.The effect of cell synchronization on the efficiency of stable gene transfer by electroporation.[18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil.Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II.A milk growth factor extract reduces chemotherapeutic drug toxicity in epithelial cells in vitro.Etoposide sensitivity and topoisomerase II activity in Chinese hamster V79 monolayers and small spheroids.Multidrug Resistance in Leukaemia.Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II.TOP2B: The First Thirty Years
P2860
Q24550865-16926C40-9799-43D4-B3A8-248F61DCFE44Q24644470-85ECBEC4-AC3F-45CC-86C0-D656E10B3D91Q27300740-790C7C4E-6A84-4508-9FBC-31E7415E67BCQ28247462-1C09588C-4048-4836-80F3-A221A1EFD96CQ33467361-80AE8033-EFB9-4E1B-891F-755C2B8EFFAAQ34210998-C95DD55B-96BC-4D80-B9FC-79D41FE4C780Q34467322-C1B79275-AD62-49EC-B545-E9AB076DAADCQ34612613-139388A1-1630-4444-9545-9F322DE111C2Q34663843-4CA47389-7FE2-4CBD-8199-8DCCC28532B1Q35259390-C2CBBA7F-3BD0-48AE-994E-7994C472F5B1Q35462471-DFD7BFB7-03BC-4C35-8FD9-D1368710EFFFQ35976079-742A35FF-EDFF-409C-9F4B-B499F61242D1Q36295044-9A3A947F-1859-494D-8D57-650227EADC49Q36360000-7792A735-D003-4ABE-A07C-AD9B78B62B90Q36465770-BB1D8C77-55AD-4C1A-9577-4A2A4485747AQ36758651-CFEE6F3D-CA3E-40E1-8061-954891C27B5BQ36791826-9928941C-9330-446E-8CC0-78A989866B22Q36797266-BC951719-9EDC-4370-9BF3-F5368D96F92CQ37601249-CC0E28E6-D1B7-483E-BEB0-6573F383C5C9Q39834950-C4854318-6350-45FF-87A5-93D49FFE2427Q39888751-D11B8C49-92FC-4512-9F30-933A92C541D8Q40664500-023C05D8-F293-457F-B386-5DBD47144EB5Q40818137-4E284086-C109-4A7A-B6AE-70C99DFDC3D8Q41347091-FA53D8A6-3D80-4FA2-9456-D8A0181A99EFQ41359103-7759EBA9-9BB3-4C6D-8C83-E027FD9DD794Q41456758-650DB5C2-41F5-4887-BABB-1B814E697C31Q41639312-9D0023B7-B596-4075-9149-5A133177E489Q41763061-C64569B6-2B26-40D2-8617-6B5A5BEDC855Q41847423-3DD26B1A-8255-49DC-8B37-6ED7D0CE2E20Q41987666-9FE37CB5-AC90-4E80-9AB8-48DFB277CB86Q42810685-4EB20EB7-7D45-4C9E-9E1B-A0A797D9FB6CQ43712663-9391CE00-71CF-4E6D-998E-DBB07AC70A40Q54290061-156937E1-72E0-4AF8-884A-D48E85BA048DQ54332338-AB07BE43-749E-4385-88AD-7F9ED8246835Q55033660-7A236726-CD5F-462C-8055-80C799800A7FQ58738913-010578D2-78CF-4F94-B5E8-D0BAD62C55F5
P2860
Topoisomerase-specific drug sensitivity in relation to cell cycle progression.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Topoisomerase-specific drug sensitivity in relation to cell cycle progression.
@en
type
label
Topoisomerase-specific drug sensitivity in relation to cell cycle progression.
@en
prefLabel
Topoisomerase-specific drug sensitivity in relation to cell cycle progression.
@en
P2860
P356
P1476
Topoisomerase-specific drug sensitivity in relation to cell cycle progression.
@en
P2093
P2860
P304
P356
10.1128/MCB.7.9.3119
P407
P577
1987-09-01T00:00:00Z